VeriMombifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment specifically flagging reproductive hazard for a 'bifidobacterium/lactobacillus/streptococcus/Panax notoginseng rhizome/root extract ferment filtrate'. Peer-reviewed literature does not provide convincing evidence of reproductive/teratogenic effects from topical cosmetic use of Panax notoginseng derivatives. Default conservative approach (CIR 'safe as used' rule) yields no hazard classification.
Related ingredients
Frequently asked questions
- bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment specifically flagging reproductive hazard for a 'bifidobacterium/lactobacillus/streptococcus/Panax notoginseng rhizome/root extract ferment filtrate'. Peer-reviewed literature does not provide convincing evidence of reproductive/teratogenic effects from topical cosmetic use of Panax notoginseng derivatives. Default conservative approach (CIR 'safe as used' rule) yields no hazard classification.
- bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate emzirirken güvenli mi?
- No authoritative sources (CIR, SCCS, ECHA harmonised CLP) identify lactation-specific risks for this ferment filtrate. Systemic exposure from normal topical cosmetic use is expected to be negligible, so transfer via breast milk is unlikely based on available regulatory and literature information.
- bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate bebek cildi için güvenli mi?
- No evidence of developmental or infant-specific reproductive toxicity. However, infant skin has a higher surface-area-to-weight ratio and an immature barrier; although adult topical absorption is expected to be negligible, a precautionary increase in exposure score to 1 for ages 0–3 is applied. There is no infant-specific mechanistic evidence to increase h or m.
- VeriMom bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate nasıl puanlıyor?
- VeriMom bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte bifidobacterium/lactobacillus/streptococcus/panax notoginseng rhizome/root extract ferment filtrate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.